Indefinite Delivery Contract SPE2DB24D9227
- Not listed
- The Defense Logistics Agency (DLA) awarded a single-award Indefinite Delivery Contract (IDC) valued at up to $499,999,999 to DMS Pharmaceutical Group Inc., a for-profit, woman-owned small business. The contract, which runs through December 31, 2025, enables DLA to issue firm fixed-price delivery orders for a broad range of pharmaceutical products to support the recurring medical supply needs of military health facilities worldwide. Key product categories include branded and generic medications...
- The Defense Logistics Agency (DLA) awarded a single-award indefinite delivery contract (IDC) 4600082013 under the SPE2DB program to DMS Pharmaceutical Group Inc., a woman-owned small business based in Park Ridge, Illinois. The contract has a potential value of up to $499,999,999 and a period of performance through December 31, 2025. Under this IDC, DMS Pharmaceutical Group will provide a broad range of pharmaceutical items to fulfill the recurring medical supply needs of military health...
- The Defense Logistics Agency (DLA) awarded a single-award Indefinite Delivery Contract (IDC) valued at up to $499,999,999 to DMS Pharmaceutical Group Inc., a woman-owned small business pharmaceutical wholesaler. This IDC, under the SPE2DB program, allows the DLA to issue firm fixed-price delivery orders for a comprehensive range of pharmaceutical products and medical supplies to support the recurring medical needs of military health facilities worldwide. Through this contract, DMS Pharmaceutical...
- The Defense Logistics Agency (DLA) has awarded a single-award Indefinite Delivery Contract (IDC) valued at $499,999,999 to DMS Pharmaceutical Group Inc., a woman-owned small business pharmaceutical wholesaler, to provide a comprehensive range of pharmaceutical products and medical supplies to support the recurring medical needs of military healthcare facilities and veterans' medical centers nationwide. The contract, which is valid through November 2026, covers an extensive portfolio of branded...
- The Defense Logistics Agency (DLA) awarded an Indefinite Delivery Contract (IDC) with a ceiling value of $499,999,999 to DMS Pharmaceutical Group Inc., a woman-owned small business pharmaceutical wholesaler, to provide a wide range of pharmaceutical products and medical supplies to support the recurring medical needs of military health facilities worldwide. The single-award IDC, which runs through November 30, 2026, covers a comprehensive array of pharmaceuticals, including branded and generic...
- The Defense Logistics Agency (DLA) awarded DMS Pharmaceutical Group Inc., a for-profit, woman-owned small business, a single-award indefinite delivery contract valued at up to $499,999,999 through December 31, 2025. This contract, under the SPE2DB program, enables DLA to issue firm fixed-price delivery orders for a broad range of pharmaceutical items including flumazenil injection, prednisone tablets, ampicillin injections, clotrimazole cream, epinephrine auto-injectors, and other branded and...
- The Defense Logistics Agency (DLA) awarded a $499,999,999 Indefinite Delivery Contract (IDC) to DMS Pharmaceutical Group Inc., a woman-owned small business pharmaceutical wholesaler, to provide a wide range of pharmaceutical products and medical supplies. The IDC, under the SPE2DB program, enables DLA to issue firm fixed-price delivery orders for branded and generic prescription drugs, over-the-counter medications, biologics, and medical consumables to support the recurring medical needs of...
- The Defense Logistics Agency (DLA) Troop Support Medical Supply Chain has awarded a single-award Indefinite Delivery Contract (IDC) valued at $499,999,999 to DMS Pharmaceutical Group Inc., a woman-owned small business, to provide a comprehensive range of pharmaceutical products and medical supplies to military healthcare facilities worldwide. The IDC, awarded under the SPE2DB program, covers an extensive portfolio of branded and generic prescription drugs, over-the-counter medications,...
- The Defense Logistics Agency (DLA) has awarded a single-award Indefinite Delivery Contract (IDC) to DMS Pharmaceutical Group Inc., a woman-owned small business pharmaceutical wholesaler, to provide a comprehensive range of pharmaceutical products and medical supplies to support the recurring medical needs of military healthcare facilities and veterans' medical centers nationwide. The $499,999,999 IDC, valid through November 2026, enables DLA to issue firm fixed-price delivery orders for...
- The Defense Logistics Agency (DLA) awarded a single-award indefinite delivery contract (IDC) valued up to $499,999,999 to DMS Pharmaceutical Group Inc., a woman-owned small business pharmaceutical wholesaler. This IDC, which runs through December 31, 2025, allows the DLA to issue firm fixed-price delivery orders for a comprehensive range of pharmaceutical items, including branded and generic prescription drugs, over-the-counter medications, biologics, and medical consumables, to fulfill the...
- SPE2DB24D9227Indefinite Delivery Contract
- 66Federal Contract Awards
The Defense Logistics Agency (DLA) awarded a single-award indefinite delivery contract (IDC) valued at up to $499,999,999 to DMS Pharmaceutical Group Inc., a woman-owned small business, to provide a broad range of pharmaceutical products and medical supplies to military health facilities globally. The contract, known as SPE2DB, has a period of performance through December 31, 2025. Under this IDC, DMS Pharmaceutical Group will deliver a variety of branded and generic medications, including naltrexone tablets, botulinum toxin injections, contraceptive implants and intrauterine devices, chemotherapy drugs, HIV antiretrovirals, ophthalmic solutions, injectable anesthetics, and other pharmaceutical items across nearly every therapeutic class. The contract also covers specialized biologics requiring cold chain logistics, as well as medical consumables such as surgical detergent solutions, artificial tears, and testosterone gels. This IDC complements DMS Pharmaceutical Group's existing prime vendor contracts for direct distribution of prescription drugs and pharmacy services to Department of Defense sites.
Mod # | Description | ReasonForModification | Federal Obligation | Date |
|---|---|---|---|---|
| Not listed | Not listed | $0 | 2/6/24 |
Name | Description | Awardee | Potential Value | AwardDate | CompletionDate | Updated At |
|---|---|---|---|---|---|---|
Delivery Order SPE2DB24D9227-SPE2DB24FANJG | DMS Pharmaceutical Group Inc. | $4.3k | 8/1/24 | 8/2/24 | 8/1/24 | |
Delivery Order SPE2DB24D9227-SPE2DB25FANJA | DMS Pharmaceutical Group Inc. | $4.3k | 3/10/25 | 3/11/25 | 3/10/25 | |
Delivery Order SPE2DB24D9227-SPE2DB25FANKJ | DMS Pharmaceutical Group Inc. | $1.2k | 8/19/25 | 8/20/25 | 8/19/25 | |
Delivery Order SPE2DB24D9227-SPE2DB24FANJP | DMS Pharmaceutical Group Inc. | $3.8k | 8/22/24 | 8/23/24 | 8/22/24 | |
Delivery Order SPE2DB24D9227-SPE2DB25FANKT | DMS Pharmaceutical Group Inc. | $4.3k | 9/26/25 | 9/29/25 | 9/26/25 |
Name | Description | Solicitation Number | FederalAgency | Type | PostedDate |
|---|---|---|---|---|---|
Pharmaceutical Prime Vendor Global | SPM2DP-13-R-0007 | Defense Logistics Agency Troop Support Medical | Award Notice 1/1 | 8/20/13, 10:37 AM |